P
Paula L. Bockenstedt
Researcher at University of Michigan
Publications - 43
Citations - 2580
Paula L. Bockenstedt is an academic researcher from University of Michigan. The author has contributed to research in topics: Antiphospholipid syndrome & Population. The author has an hindex of 24, co-authored 43 publications receiving 2190 citations. Previous affiliations of Paula L. Bockenstedt include Imperial College London & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Venous thromboembolic disease
Lawrence D. Wagman,Melissa F. Baird,Charles L. Bennett,Paula L. Bockenstedt,Spero R. Cataland,John Fanikos,Patrick F. Fogarty,Samuel Z. Goldhaber,Tejpal Grover,William Haire,Hani Hassoun,Suzanne Hutchinson,Mohammad Jahanzeb,Jason T. Lee,Michael L. Linenberger,Michael Millenson,Thomas L. Ortel,Riad Salem,Judy L. Smith,Michael B. Streiff,Suresh Vedantham +20 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for VTE provide recommendations on risk evaluation, diagnosis, prevention, and treatment of VTE in patients with cancer.
Journal ArticleDOI
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome
Srilakshmi Yalavarthi,Travis J. Gould,Ashish N. Rao,Levi F. Mazza,Alexandra E. Morris,Carlos A. Núñez-Álvarez,Diego F. Hernández-Ramírez,Paula L. Bockenstedt,Patricia C. Liaw,Antonio R. Cabral,Jason S. Knight +10 more
TL;DR: In this paper, the interaction of antiphospholipid antibodies (aPL) with neutrophils has been extensively studied to determine whether aPL activate neutrophil to release extracellular traps (NETs), thereby predisposing to the arterial and venous thrombosis inherent in the APS.
Journal ArticleDOI
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
Wagman Ld,Melissa F. Baird,Charles L. Bennett,Paula L. Bockenstedt,Cataland,John Fanikos,Patrick F. Fogarty,Samuel Z. Goldhaber,Tejpal Grover,W.D. Haire,Hani Hassoun,Hutchinson S,Mohammad Jahanzeb,Jason T. Lee,Michael L. Linenberger,Michael Millenson,Thomas L. Ortel,Riad Salem,Judy L. Smith,Michael B. Streiff,Suresh Vedantham +20 more
Journal ArticleDOI
NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines
Michael B. Streiff,Bjorn Holmstrom,Dana Angelini,Aneel A. Ashrani,Paula L. Bockenstedt,Carolyn M. Chesney,John Fanikos,Randolph B. Fenninger,Annemarie E. Fogerty,Shuwei Gao,Samuel Z. Goldhaber,Krishna Gundabolu,Paul C. Hendrie,Alfred Lee,Jason T. Lee,Janelle Mann,Brandon McMahon,Michael Millenson,Colleen Morton,Thomas L. Ortel,Sadat Ozair,Rita Paschal,Sanford J. Shattil,Tanya Siddiqi,Kristi J. Smock,Gerald A. Soff,Tzu-Fei Wang,Eliot C. Williams,Anaadriana Zakarija,Lydia J. Hammond,Mary A. Dwyer,Anita M. Engh +31 more
TL;DR: The NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.
Journal ArticleDOI
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Asra Ahmed,Samuel A. Merrill,Fares Alsawah,Paula L. Bockenstedt,Erica L. Campagnaro,Sumana Devata,Scott D. Gitlin,Mark S. Kaminski,Alice M. Cusick,Tycel Phillips,Suman L. Sood,Moshe Talpaz,Albert Thomas Quiery,Philip S. Boonstra,Ryan A. Wilcox +14 more
TL;DR: Preliminary data suggest that ruxolitinib is active, well tolerated, and manageable in the outpatient setting in patients with secondary haemophagocytic lymphohistiocytosis and other cytokine-release syndromes and warrant further investigation.